Direct medical costs of pediatric asthma exacerbations requiring hospital attendance in a middle-income country

dc.contributor.authorRodriguez-Martinez, C.E.
dc.contributor.authorSossa-Briceño, M.P.
dc.contributor.authorCastro-Rodriguez, J.A.
dc.date.accessioned2020-05-12T21:05:52Z
dc.date.available2020-05-12T21:05:52Z
dc.date.issued2020
dc.description.abstractenglishINTRODUCTION AND OBJECTIVES: With the aim of making informed decisions on resource allocation, there is a critical need for studies that provide accurate information on hospital costs for treating pediatric asthma exacerbations, mainly in middle-income countries (MICs). The aim of the present study was to evaluate the direct medical costs associated with pediatric asthma exacerbations requiring hospital attendance in Bogota, Colombia. PATIENTS AND METHODS: We reviewed the available electronic medical records (EMRs) for all pediatric patients who were admitted to the Fundacion Hospital de La Misericordia with a discharge principal diagnosis pediatric asthma exacerbation over a 24-month period from January 2016 to December 2017. Direct medical costs of pediatric asthma exacerbations were retrospectively collected by dividing the patients into four groups: those admitted to the emergency department (ED) only; those admitted to the pediatric ward (PW); those admitted to the pediatric intermediate care unit (PIMC); and those admitted to the pediatric intensive care unit (PICU). RESULTS: A total of 252 patients with a median (IQR) age of 5.0 (3.0-7.0) years were analyzed, of whom 142 (56.3%) were males. Overall, the median (IQR) cost of patients treated in the ED, PW, PIMC, and PICU was US$38.8 (21.1-64.1) vs. US$260.5 (113.7-567.4) vs. 1212.4 (717.6-1609.6) vs. 2501.8 (1771.6-3405.0), respectively: this difference was statistically significant (p<0.001). CONCLUSIONS: The present study helps to further our understanding of the economic burden of pediatric asthma exacerbations requiring hospital attendance among pediatric patients in a MIC.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1016/j.aller.2019.06.015
dc.identifier.issn0301-0546
dc.identifier.urihttps://hdl.handle.net/20.500.12495/2645
dc.language.isoeng
dc.publisherElsevierspa
dc.publisher.journalAllergologia et immunopathologiaspa
dc.relation.ispartofseriesAllergologia et immunopathologia, 0301-0546, Vol 48, Num 2, 2020, pag 142-148spa
dc.relation.urihttps://www.elsevier.es/en-revista-allergologia-et-immunopathologia-105-linkresolver-direct-medical-costs-pediatric-asthma-S0301054619301168
dc.rights.creativecommons2019
dc.rights.localAcceso cerradospa
dc.subject.armarcDesarrollo económicospa
dc.subject.decsAsmaspa
dc.subject.decsObstrucción de las vías aéreasspa
dc.subject.keywordsAsthma attackspa
dc.subject.keywordsDirect cost itemsspa
dc.subject.keywordsHealth economicsspa
dc.subject.keywordsHospitalization costsspa
dc.subject.keywordsLength of stayspa
dc.titleDirect medical costs of pediatric asthma exacerbations requiring hospital attendance in a middle-income countryspa
dc.title.translatedDirect medical costs of pediatric asthma exacerbations requiring hospital attendance in a middle-income countryspa
dc.typearticlespa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersion
dc.type.localartículospa

Archivos

Bloque original
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
Archivo en blanco.txt
Tamaño:
16 B
Formato:
Plain Text
Descripción:
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:

Colecciones